Remarkably, giant GC as well as increased TFH and TPH cells resolved in the AID-ΔE4a patients after initiation of IRT, suggesting that provision of correctly mutated antibodies besides preventing severe infections may also dampen immune dysregulation in these patients. This evidence concerns the gene AICDA and infection.